Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Pediatric Glioma at the Optic Pathway and Thalamus

  • Park, Eun Suk (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Park, Jun Bum (Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Ra, Young-Shin (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2018.02.14
  • Accepted : 2018.03.29
  • Published : 2018.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Gliomas are the most common pediatric tumors of the central nervous system. In this review, we discuss the clinical features, treatment paradigms, and evolving concepts related to two types of pediatric gliomas affecting two main locations: the optic pathway and thalamus. In particular, we discuss recently revised pathologic classification, which adopting molecular parameter. We believe that our review contribute to the readers' better understanding of pediatric glioma because pediatric glioma differs in many ways from adult glioma according to the newest advances in molecular characterization of this tumor. A better understanding of current and evolving issues in pediatric glioma is needed to ensure effective management decision.

Keywords

References

  1. Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, et al. : Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol 13 : 223-234, 2011 https://doi.org/10.1093/neuonc/noq178
  2. Astrup J : Natural history and clinical management of optic pathway glioma. Br J Neurosurg 17 : 327-335, 2003 https://doi.org/10.1080/02688690310001601216
  3. Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, et al. : Randomized study of two chemotherapy regimens for treatment of lowgrade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol 30 : 2641-2647, 2012 https://doi.org/10.1200/JCO.2011.36.6054
  4. Avery RA, Fisher MJ, Liu GT : Optic pathway gliomas. J Neuroophthalmol 31 : 269-278, 2011 https://doi.org/10.1097/WNO.0b013e31822aef82
  5. Avery RA, Hwang EI, Jakacki RI, Packer RJ : Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab. JAMA Ophthalmol 132 : 111-114, 2014 https://doi.org/10.1001/jamaophthalmol.2013.5819
  6. Baroncini M, Vinchon M, Mineo JF, Pichon F, Francke JP, Dhellemmes P : Surgical resection of thalamic tumors in children: approaches and clinical results. Childs Nerv Syst 23 : 753-760, 2007 https://doi.org/10.1007/s00381-007-0299-4
  7. Bilginer B, Narin F, Isikay I, Oguz KK, Soylemezoglu F, Akalan N : Thalamic tumors in children. Childs Nerv Syst 30 : 1493-1498, 2014 https://doi.org/10.1007/s00381-014-2420-9
  8. Binning MJ, Liu JK, Kestle JR, Brockmeyer DL, Walker ML : Optic pathway gliomas: a review. Neurosurg Focus 23 : E2, 2007
  9. Borghei-Razavi H, Shibao S, Schick U : Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome. Neurosurg Rev 40 : 135-141, 2017 https://doi.org/10.1007/s10143-016-0747-2
  10. Borja MJ, Plaza MJ, Altman N, Saigal G : Conventional and advanced MRI features of pediatric intracranial tumors: supratentorial tumors. AJR Am J Roentgenol 200 : W483-W503, 2013 https://doi.org/10.2214/AJR.12.9724
  11. Braunstein S, Raleigh D, Bindra R, Mueller S, Haas-Kogan D : Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. J Neurooncol 134 : 541-549, 2017 https://doi.org/10.1007/s11060-017-2393-0
  12. Broadway SJ, Ogg RJ, Scoggins MA, Sanford R, Patay Z, Boop FA : Surgical management of tumors producing the thalamopeduncular syndrome of childhood. J Neurosurg Pediatr 7 : 589-595, 2011 https://doi.org/10.3171/2011.4.PEDS119
  13. Burger PC, Cohen KJ, Rosenblum MK, Tihan T : Pathology of diencephalic astrocytomas. Pediatr Neurosurg 32 : 214-219, 2000 https://doi.org/10.1159/000028937
  14. Cao L, Li C, Zhang Y, Gui S : Surgical resection of unilateral thalamic tumors in adults: approaches and outcomes. BMC Neurol 15 : 229, 2015 https://doi.org/10.1186/s12883-015-0487-x
  15. Cappelli C, Grill J, Raquin M, Pierre-Kahn A, Lellouch-Tubiana A, Terrier-Lacombe MJ, et al. : Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child 79 : 334-338, 1998 https://doi.org/10.1136/adc.79.4.334
  16. Cheek WR, Taveras JM : Thalamic tumors. J Neurosurg 24 : 505-513, 1966 https://doi.org/10.3171/jns.1966.24.2.0505
  17. Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, et al. : Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol 13 : 317-323, 2011 https://doi.org/10.1093/neuonc/noq191
  18. Combs SE, Schulz-Ertner D, Moschos D, Thilmann C, Huber PE, Debus J : Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 62 : 814-819, 2005 https://doi.org/10.1016/j.ijrobp.2004.12.081
  19. Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH : Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res 65 : 2755-2760, 2005 https://doi.org/10.1158/0008-5472.CAN-04-4058
  20. Desai SS, Paulino AC, Mai WY, Teh BS : Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys 65 : 1222-1227, 2006 https://doi.org/10.1016/j.ijrobp.2006.01.038
  21. Dodge HW Jr, Love JG, Craig WM, Dockerty MB, Kearns TP, Holman CB, et al. : Gliomas of the optic nerves. AMA Arch Neurol Psychiatry 79 : 607-621, 1958 https://doi.org/10.1001/archneurpsyc.1958.02340060003001
  22. El-Shehaby AM, Reda WA, Abdel Karim KM, Emad Eldin RM, Nabeel AM : Single-session Gamma knife radiosurgery for optic pathway/hypothalamic gliomas. J Neurosurg 125(1 Suppl) : 50-57, 2016
  23. Finlay JL, Zacharoulis S : The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical-and futuristic-perspective. J Neurooncol 75 : 253-266, 2005 https://doi.org/10.1007/s11060-005-6747-7
  24. Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, et al. : Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14 : 790-797, 2012 https://doi.org/10.1093/neuonc/nos076
  25. Franzini A, Leocata F, Cajola L, Servello D, Allegranza A, Broggi G : Lowgrade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal. Neurosurgery 35 : 817-820; discussion 820-821, 1994 https://doi.org/10.1227/00006123-199411000-00003
  26. Goodden JMC : Optic Pathway Hypothalamic Glioma in Winn HR (ed) : Youmans and Winn Neurological Surgery, ed 7th. Philadelphia : Elsevier, 2016, pp1660-1667
  27. Grabenbauer GG, Schuchardt U, Buchfelder M, Rodel CM, Gusek G, Marx M, et al. : Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol 54 : 239-245, 2000 https://doi.org/10.1016/S0167-8140(00)00149-3
  28. Grill J, Couanet D, Cappelli C, Habrand JL, Rodriguez D, Sainte-Rose C, et al. : Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45 : 393-396, 1999 https://doi.org/10.1002/1531-8249(199903)45:3<393::AID-ANA17>3.0.CO;2-B
  29. Gupta A, Shaller N, McFadden KA : Pediatric thalamic gliomas: an updated review. Arch Pathol Lab Med 141 : 1316-1323, 2017 https://doi.org/10.5858/arpa.2017-0249-RA
  30. Gutmann DH, Donahoe J, Brown T, James CD, Perry A : Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol 26 : 361-367, 2000 https://doi.org/10.1046/j.1365-2990.2000.00258.x
  31. Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker LE, Jenkin D, et al. : Optic pathway/hypothalamic gliomas: a dilemma in management. Pediatr Neurosurg 19 : 186-195, 1993 https://doi.org/10.1159/000120729
  32. Hoffman HJ, Soloniuk DS, Humphreys RP, Drake JM, Becker LE, De Lima BO, et al. : Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. Neurosurgery 33 : 964-971, 1993
  33. Horwich A, Bloom HJ : Optic gliomas: radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 11 : 1067-1079, 1985 https://doi.org/10.1016/0360-3016(85)90052-5
  34. Hoyt WF, Baghdassarian SA : Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol 53 : 793-798, 1969 https://doi.org/10.1136/bjo.53.12.793
  35. Hummel TR, Chow LM, Fouladi M, Franz D : Pharmacotherapeutic management of pediatric gliomas: current and upcoming strategies. Paediatr Drugs 15 : 29-42, 2013 https://doi.org/10.1007/s40272-012-0002-4
  36. Jahraus CD, Tarbell NJ : Optic pathway gliomas. Pediatr Blood Cancer 46 : 586-596, 2006 https://doi.org/10.1002/pbc.20655
  37. Jeelani ODP : Thalamic Tumors in Winn HR (ed) : Youmans and Winn Neurological Surgery, ed 7th. Philadelphia : Elsevier, 2016, pp1669-1676
  38. Jones DT, Kocialkowski S, Liu L, Pearson DM, Ichimura K, Collins VP : Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 28 : 2119-2123, 2009 https://doi.org/10.1038/onc.2009.73
  39. Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K, et al. : Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68 : 8673-8677, 2008 https://doi.org/10.1158/0008-5472.CAN-08-2097
  40. Juratli TA, Qin N, Cahill DP, Filbin MG : Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas. Pharmacol Ther 182 : 70-79, 2018 https://doi.org/10.1016/j.pharmthera.2017.08.006
  41. Khatua S, Gutmann DH, Packer RJ : Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights. Pediatr Blood Cancer 65 : 2018
  42. Khatua S, Wang J, Rajaram V : Review of low-grade gliomas in children--evolving molecular era and therapeutic insights. Childs Nerv Syst 31 : 643-652, 2015 https://doi.org/10.1007/s00381-015-2653-2
  43. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, et al. : K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124 : 439-447, 2012 https://doi.org/10.1007/s00401-012-0998-0
  44. Komotar RJ, Mocco J, Carson BS, Sughrue ME, Zacharia BE, Sisti AC, et al. : Pilomyxoid astrocytoma: a review. MedGenMed 6 : 42, 2004
  45. Kornreich L, Blaser S, Schwarz M, Shuper A, Vishne TH, Cohen IJ, et al. : Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 22 : 1963-1969, 2001
  46. Kramm CM, Butenhoff S, Rausche U, Warmuth-Metz M, Kortmann RD, Pietsch T, et al. : Thalamic high-grade gliomas in children: a distinct clinical subset? Neuro Oncol 13 : 680-689, 2011 https://doi.org/10.1093/neuonc/nor045
  47. Lambron J, Rakotonjanahary J, Loisel D, Frampas E, De Carli E, Delion M, et al. : Can we improve accuracy and reliability of MRI interpretation in children with optic pathway glioma? Proposal for a reproducible imaging classification. Neuroradiology 58 : 197-208, 2016 https://doi.org/10.1007/s00234-015-1612-7
  48. Lau N, Feldkamp MM, Roncari L, Loehr AH, Shannon P, Gutmann DH, et al. : Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 59 : 759-767, 2000 https://doi.org/10.1093/jnen/59.9.759
  49. Lee AG : Neuroophthalmological management of optic pathway gliomas. Neurosurg Focus 23 : E1, 2007
  50. Lee RP, Foster KA, Lillard JC, Klimo P Jr, Ellison DW, Orr B, et al. : Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors. J Neurosurg Pediatr 20 : 247-255, 2017 https://doi.org/10.3171/2017.4.PEDS16668
  51. Leroy R, Benahmed N, Hulstaert F, Van Damme N, De Ruysscher D : Proton therapy in children: a systematic review of clinical effectiveness in 15 pediatric cancers. Int J Radiat Oncol Biol Phys 95 : 267-278, 2016 https://doi.org/10.1016/j.ijrobp.2015.10.025
  52. Listernick R, Ferner RE, Liu GT, Gutmann DH : Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61 : 189-198, 2007 https://doi.org/10.1002/ana.21107
  53. Listernick R, Louis DN, Packer RJ, Gutmann DH : Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41 : 143-149, 1997 https://doi.org/10.1002/ana.410410204
  54. Liu GT : Optic gliomas of the anterior visual pathway. Curr Opin Ophthalmol 17 : 427-431, 2006 https://doi.org/10.1097/01.icu.0000243016.90004.12
  55. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. : The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131 : 803-820, 2016 https://doi.org/10.1007/s00401-016-1545-1
  56. Maia AC Jr, Malheiros SM, da Rocha AJ, da Silva CJ, Gabbai AA, Ferraz FA, et al. : MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 26 : 777-783, 2005
  57. Massimi L, Tufo T, Di Rocco C : Management of optic-hypothalamic gliomas in children: still a challenging problem. Expert Rev Anticancer Ther 7 : 1591-1610, 2007 https://doi.org/10.1586/14737140.7.11.1591
  58. Moreno L, Bautista F, Ashley S, Duncan C, Zacharoulis S : Does chemotherapy affect the visual outcome in children with optic pathway glioma? a systematic review of the evidence. Eur J Cancer 46 : 2253-2259, 2010 https://doi.org/10.1016/j.ejca.2010.03.028
  59. Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, et al. : Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42 : 1807-1816, 2006 https://doi.org/10.1016/j.ejca.2006.02.022
  60. Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. : CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol 18 : v1-v75, 2016 https://doi.org/10.1093/neuonc/now207
  61. Ozek MM, Ture U : Surgical approach to thalamic tumors. Childs Nerv Syst 18 : 450-456, 2002 https://doi.org/10.1007/s00381-002-0608-x
  62. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, et al. : Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86 : 747-754, 1997 https://doi.org/10.3171/jns.1997.86.5.0747
  63. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, et al. : Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11 : 850-856, 1993 https://doi.org/10.1200/JCO.1993.11.5.850
  64. Panigrahy A, Bluml S : Neuroimaging of pediatric brain tumors: from basic to advanced magnetic resonance imaging (MRI). J Child Neurol 24 : 1343-1365, 2009 https://doi.org/10.1177/0883073809342129
  65. Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, et al. : Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 119 : 516-529, 2001 https://doi.org/10.1001/archopht.119.4.516
  66. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M : Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 82 : 536-547, 1995 https://doi.org/10.3171/jns.1995.82.4.0536
  67. Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, et al. : The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J Pediatr 167 : 851-856.e1, 2015 https://doi.org/10.1016/j.jpeds.2015.07.001
  68. Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA : Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32 : 235-241, 1997 https://doi.org/10.1023/A:1005736104205
  69. Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J, et al. : Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst 31 : 1773-1780, 2015 https://doi.org/10.1007/s00381-015-2832-1
  70. Puget S, Crimmins DW, Garnett MR, Grill J, Oliveira R, Boddaert N, et al. : Thalamic tumors in children: a reappraisal. J Neurosurg 106 : 354-362, 2007
  71. Pungavkar SA, Lawande MA, Patkar DP, Agrawal NV, Gadani S : Bilateral optic pathway glioma with intracranial calcification: magnetic resonance imaging and magnetic resonance spectroscopy findings. Australas Radiol 49 : 489-492, 2005 https://doi.org/10.1111/j.1440-1673.2005.01442.x
  72. Rasool N, Odel JG, Kazim M : Optic pathway glioma of childhood. Curr Opin Ophthalmol 28 : 289-295, 2017 https://doi.org/10.1097/ICU.0000000000000370
  73. Rodriguez FJ, Vizcaino MA, Lin MT : Recent advances on the molecular pathology of glial neoplasms in children and adults. J Mol Diagn 18 : 620-634, 2016 https://doi.org/10.1016/j.jmoldx.2016.05.005
  74. Sai Kiran NA, Thakar S, Dadlani R, Mohan D, Furtado SV, Ghosal N, et al. : Surgical management of thalamic gliomas: case selection, technical considerations, and review of literature. Neurosurg Rev 36 : 383-393, 2013 https://doi.org/10.1007/s10143-013-0452-3
  75. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, et al. : Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482 : 226-231, 2012 https://doi.org/10.1038/nature10833
  76. Shapey J, Danesh-Meyer HV, Kaye AH : Diagnosis and management of optic nerve glioma. J Clin Neurosci 18 : 1585-1591, 2011 https://doi.org/10.1016/j.jocn.2011.09.003
  77. Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, et al. : Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24 : 2570-2575, 2006 https://doi.org/10.1200/JCO.2005.03.8349
  78. Shen TT, Sakai O, Curtin HD, Rizzo JF 3rd : Magnetic resonance imaging of primary anterior visual pathway tumors. Int Ophthalmol Clin 41 : 171-180, 2001 https://doi.org/10.1097/00004397-200101000-00016
  79. Steinbok P, Gopalakrishnan CV, Hengel AR, Vitali AM, Poskitt K, Hawkins C, et al. : Pediatric thalamic tumors in the MRI era: a Canadian perspective. Childs Nerv Syst 32 : 269-280, 2016 https://doi.org/10.1007/s00381-015-2968-z
  80. Stieber VW : Radiation therapy for visual pathway tumors. J Neuroophthalmol 28 : 222-230, 2008 https://doi.org/10.1097/WNO.0b013e318177ee9d
  81. Sturm D, Pfister SM, Jones DTW : Pediatric gliomas: current concepts on diagnosis, biology, and clinical management. J Clin Oncol 35 : 2370-2377, 2017 https://doi.org/10.1200/JCO.2017.73.0242
  82. Suarez JC, Viano JC, Zunino S, Herrera EJ, Gomez J, Tramunt B, et al. : Management of child optic pathway gliomas: new therapeutical option. Childs Nerv Syst 22 : 679-684, 2006 https://doi.org/10.1007/s00381-005-0021-3
  83. Sylvester CL, Drohan LA, Sergott RC : Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. Curr Opin Ophthalmol 17 : 7-11, 2006 https://doi.org/10.1097/01.icu.0000193070.32369.37
  84. Wisoff JH, Abbott R, Epstein F : Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73 : 661-667, 1990 https://doi.org/10.3171/jns.1990.73.5.0661
  85. Wong TT, Chen HH, Liang ML, Hsieh KL, Yang YS, Ho DM, et al. : Clinical considerations and surgical approaches for low-grade gliomas in deep hemispheric locations: thalamic lesions. Childs Nerv Syst 32 : 1895-1906, 2016 https://doi.org/10.1007/s00381-016-3148-5
  86. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, et al. : Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44 : 251-253, 2012 https://doi.org/10.1038/ng.1102
  87. Yeom KW, Lober RM, Andre JB, Fisher PG, Barnes PD, Edwards MS, et al. : Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma. J Neurooncol 113 : 479-483, 2013 https://doi.org/10.1007/s11060-013-1140-4

Cited by

  1. Diagnostic accuracy of neuroimaging in pediatric optic chiasm/sellar/suprasellar tumors vol.66, pp.6, 2019, https://doi.org/10.1002/pbc.27680
  2. 68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma vol.46, pp.10, 2018, https://doi.org/10.1007/s00259-019-04392-7
  3. Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics vol.35, pp.12, 2018, https://doi.org/10.1177/0883073820937225